Where do you standin pulmonology?
Twenty real cases build your private map: where you’re solid, what to brush up. Nobody grades you.
8 minutes · one case · no account needed
Your CME hours, aimed at your real gaps.
Diagnoses in this area unlock as you solve cases.
Built and reviewed by practicing pulmonologists.
Cases, scoring, and debriefs are built with a faculty committee spanning pulmonary, critical care, and sleep medicine.
Faculty names appear here as each reviewer confirms and completes disclosure.
The committee is being assembled across pulmonary subspecialty areas.
See how you think. See where you stand.
Pulmonology is rarely about knowing one right answer. It’s about deciding what to do next. Work a real case, then compare your decisions with pulmonologists across the country.
- About 8 minutes, no account needed
- Designated for 0.25 AMA PRA Category 1 Credit™
- Anonymous ranking, state and national
Normal spirometry.
Breathless on the stairs.
So far: Inhalers started empirically, no response. Chest X-ray read as normal.
On testing: Spirometry near-normal. Symptoms out of proportion to it.
Question: What do you order next — and what are you ruling out?
The Fall Finals. Drop in anytime.
Enter the Fall Finals, earn CME credit case by case, and compete for a place in the national pulmonology standings for 2026.
Fall Finals open
20 branching simulations, 16 accredited for CME credit.
Fall Finals close
Last day to complete cases and claim credit.
Championship Awards
Live virtual ceremony. National and state titles announced.
National recognition. Earned, not assigned.
No nominations and no institutional gatekeeping. The leaderboard reflects the decisions you make inside the same clinical challenges as pulmonologists nationwide.
Champion of US Pulmonology 2026
Top performer in the Championship Finals, announced live in December. The national title for US community pulmonologists.
National Frontline
The physicians who first see, screen, and route the hard cases. Top 20 nationally for 2026.
State Champion of Pulmonology 2026
Top performer in each state with at least 10 participants. State Frontline awarded in states with deeper fields.
Two ways to compete.
The simulator is the core of the program — duels put your reasoning to the test head-to-head.
Clinical Simulator
Work a full patient case the way you would in clinic, with feedback at every step.
Duel
Challenge another pulmonologist to ten focused questions and earn points for the leaderboard.
Points from cases and duels rank you on national and state leaderboards. CME credit is earned only through the accredited simulations — duels and the leaderboard carry no separate credit.
CME Credit
Accumulate credits based on time spent viewing individual cases
and claim credits at your convenience.
Up to 4.0 AMA PRA Category 1 Credits™
Earned case by case across the Fall Finals. Claim only the credit commensurate with your participation.
Up to 4.0 ABIM MOC points
Registered for ABIM MOC. Claim only the points commensurate with your participation.
The Opening Case is designated for 0.25 credits
Free, no full registration. Start it now, then claim the 0.25 credit with your name and email.
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Eximion Medical Education. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Faculty disclosures, AI use and how to claim credit: Accreditation Information.
Validated methodology The same simulation engine, proven in its oncology debut season.
Questions, answered.
The practical details before you start your first case.
Yes. No fee, no membership, no payment details. It's open to any US pulmonologist with an active NPI. A one-time NPI check applies only when you enter the ranked championship; the Opening Case needs no account at all.
Up to 15 minutes per simulation. You work through cases at your own pace, one sitting or many.
Up to 4 hours total for the accredited cases in a season. You can earn 0.25 CME credits per accredited case, up to 4.0 per season.
Yes. The simulations run in your browser on phone, tablet, or desktop. There's no app to install.
That's fine. Drop in and out at any point. Every credit you claim is yours to keep, whether you complete one case or all of them.
Your decisions are benchmarked anonymously against the national field. Everyone competes anonymously under a pseudonym; your real name and affiliation are never shown to anyone, including other participants.
Accreditation Information
Faculty information and their financial disclosures, AI Use Disclosure, and how to claim credit.
Upon completion of this program, participants will be able to:
- Recognize the clinical presentation patterns of pulmonary arterial hypertension — including unexplained dyspnea on exertion, exercise intolerance, syncope, chest pain, peripheral edema, and right heart failure signs — to differentiate PAH from conditions that commonly delay diagnosis, including COPD, asthma, interstitial lung disease, deconditioning, and left heart failure.
- Apply evidence-based diagnostic algorithms for pulmonary hypertension, including appropriate selection and interpretation of echocardiography with right ventricular pressure estimation, V/Q scanning, right heart catheterization, NT-proBNP, pulmonary function testing with DLCO, and autoimmune serologies, in accordance with ESC/ERS 2022 guidelines and WHO hemodynamic diagnostic criteria.
- Differentiate WHO Group 1 pulmonary arterial hypertension from Group 2 (left heart disease–associated), Group 3 (lung disease–associated), and Group 4 (chronic thromboembolic) pulmonary hypertension based on clinical features, hemodynamic findings, and diagnostic workup, recognizing the implications for treatment selection and referral.
- Evaluate the current and emerging PAH therapeutic landscape — including endothelin receptor antagonists, PDE5 inhibitors, soluble guanylate cyclase stimulators, prostacyclin pathway agents, and activin signaling inhibitors — to apply risk-stratified treatment algorithms using an evidence-based framework consistent with current clinical guidelines.
- Demonstrate improved clinical decision-making in simulated PAH diagnostic scenarios, including reduced time-to-diagnosis, increased diagnostic accuracy, and appropriate utilization of confirmatory investigations.
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Planner/reviewer for this educational activity, has the following relevant financial relationships:
- Consultant, advisor, or speaker for Gossamer Bio and Merck (both relationships have ended)
- Researcher for Merck and United Therapeutics (the United Therapeutics relationship has ended)
Planner/reviewer for this educational activity, has the following relevant financial relationships:
- Consultant, advisor, or speaker for Boehringer Ingelheim, Insmed, Merck, Renovion, and UCB (the Renovion relationship has ended)
Planner/reviewer for this educational activity, has the following relevant financial relationships:
- Consultant, advisor, or speaker for Merck, OrphAI, and United Therapeutics
- Data Safety Monitoring Board (DSMB) Chair for Insmed
Planner/reviewer for this educational activity, has the following relevant financial relationships:
- Researcher for Verona/Merck Pharmaceuticals and Boehringer Ingelheim (the Boehringer Ingelheim relationship has ended)
This activity is developed and delivered with AI assistance. Some cases are developed entirely by faculty without AI. Where AI is used, it assists faculty, who set and validate the correct clinical pathway for every case. All AI-assisted content is reviewed by qualified faculty reviewers to confirm relevance, scientific accuracy, and alignment with the educational scope of the activity. The activity is AI-assisted, not AI-generated. The AI tool used is Claude (Anthropic), versions Opus 4.8 and Opus 5, used June 2026 through November 2026. Prompts and participant responses processed by AI are not stored externally.
How AI is used
- Drafting. AI helps draft candidate cases and decision pathways for some cases. Faculty set and validate the correct clinical pathway for every case, and qualified reviewers confirm each case for relevance, scientific accuracy, and fit with the educational scope.
- Aggregate analysis. AI performs de-identified, aggregate analysis of participant decisions at each decision node, including clustering of common errors, for educational-outcomes reporting and the design of future activities. It does not alter content for any individual during the activity.
- Identity and integrity verification. AI flags possible duplicate registrations and shared responses for human review. AI does not make registration or credit decisions. Registration is verified by the platform, with staff reviewing any flagged cases. Credit is awarded under the accreditation of Partners, the accredited provider.
Validation and oversight
- Each AI-assisted case is clinically validated by faculty before release.
- Every case passes two independent review rounds conducted by different reviewers.
- The full case mix has been reviewed and approved by faculty.
- Faculty reviewers have no relevant financial relationships and were screened for the potential to insert commercial bias.
- The designated physician reviewers can revise or discontinue any AI-assisted content.
Independence and responsibility
- Partners for Advancing Clinical Education is the accredited provider and has reviewed the educational content for accuracy, timeliness, fair balance, and to ensure that it supports safe, effective patient care.
- AI does not autonomously determine content, results, or credit.
- No commercial supporter had any role in content design, case selection, scoring methodology, or recognition.
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Eximion Medical Education, LLC. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Education. Partners designates this enduring material for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine Maintenance of Certification. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. To receive CME credit and/or MOC points, you MUST complete each simulation and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through Partner's Joint Accreditation Program and Activity Reporting System (JA-PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records. By sharing your Diplomate Board ID # and DOB, you are giving Partners permission to use this information/data to report your participation to these Boards JA-PARS.
For additional information about the accreditation of this activity, please visit partnersed.com.
Participation in this self-study activity should be completed in approximately 4 hour(s). To successfully complete this activity and receive CE credit, learners must follow these steps during the period from September 15, 2026 through November 30, 2026:
- Review the objectives and disclosures
- Study the individual cases
- Accumulate credits based on time spent within case competitions
- Complete the activity evaluation
The activity comprises 20 simulation cases. Sixteen cases are credit-bearing and are designated at 0.25 AMA PRA Category 1 Credit™ each, for a maximum of 4.0 credits. Four cases are offered as bonus educational content and carry no credit.
Disclosure of Unlabeled Use. This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This activity is delivered online and can be accessed using any of the following:
- Internet connection: Broadband/high-speed connection recommended
- Supported browsers: Current or most recent prior version of Google Chrome, Mozilla Firefox, Apple Safari, or Microsoft Edge (JavaScript and cookies must be enabled)
- Operating systems: Windows 10 or later, macOS 11 or later, iOS 15 or later, Android 10 or later
- Devices: Desktop, laptop, tablet, or smartphone with a minimum screen resolution of 1024 x 768
- Software: Adobe Acrobat Reader (or equivalent) for viewing/printing PDF materials, if applicable
- Speakers/headphones: Required if the activity includes audio or video components
No additional plug-ins or specialized software are required to participate in or complete this activity.
Start with the Opening Case.
Start with a free seven-minute challenge — no account needed. Complete it, pass a one-time NPI check, and take your place in the national pulmonology standings before the Fall Finals close November 30.
Before you start, please review the Accreditation Information.